Arkolith/Insider Trading/AZRX/Form 4

Sapirstein James

PRES, CEO & CHAIRMAN OF BOARD, DirectorAzurRx BioPharma, Inc. (AZRX) · full profile →Form 4 · filed Jul 2, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 30, 2021Other(J)900K—$0300K
Jun 30, 2021Grant(A)900K—$0900K

Transaction Codes

J
Other acquisition / disposition
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-21-003426) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML